Home
GRFS
GRFS News

Latest Grifols S.A. (GRFS) News on November 25, 2025

Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year?

Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility

Insider Monkey

2 months ago

Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

GRFS or NBIX: Which Is the Better Value Stock Right Now?

Zacks

3 months ago

GRFS or NBIX: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Grifols (GRFS) Right Now?

Zacks

3 months ago

Are Investors Undervaluing Grifols (GRFS) Right Now?

BTS and clients recognized with 59 Brandon Hall Group Excellence Awards in 2025

Business Wire

3 months ago

BTS and clients recognized with 59 Brandon Hall Group Excellence Awards in 2025

MT Newswires

3 months ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

MT Newswires

3 months ago

European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?

Zacks

5 months ago

ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?

High Growth Tech Stocks In Europe To Watch June 2025

Simply Wall St.

5 months ago

High Growth Tech Stocks In Europe To Watch June 2025

Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know

Zacks

6 months ago

Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know

Is Grifols (GRFS) Stock Undervalued Right Now?

Zacks

6 months ago

Is Grifols (GRFS) Stock Undervalued Right Now?

GRFS vs. STVN: Which Stock Is the Better Value Option?

Zacks

6 months ago

GRFS vs. STVN: Which Stock Is the Better Value Option?

MT Newswires

6 months ago

US Court Allows Grifols' Defamation Suit Against Gotham City to Proceed

US court proceeds with Grifols defamation case against Gotham City, but narrows scope

Reuters

6 months ago

US court proceeds with Grifols defamation case against Gotham City, but narrows scope

ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?

Zacks

6 months ago

ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?

FDA clears Grifols’ application for dry eye disease treatment

Clinical Trials Arena

6 months ago

FDA clears Grifols’ application for dry eye disease treatment

GRFS or NBIX: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

GRFS or NBIX: Which Is the Better Value Stock Right Now?

High Growth Tech Stocks in Europe for May 2025

Simply Wall St.

6 months ago

High Growth Tech Stocks in Europe for May 2025

Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year

TipRanks

6 months ago

Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year

Grifols reaffirms guidance for 2025

TipRanks

6 months ago

Grifols reaffirms guidance for 2025

Australia's CSL evaluates China tariff exemptions for its US-made drugs

Reuters

7 months ago

Australia's CSL evaluates China tariff exemptions for its US-made drugs

Here’s White Falcon’s Views on Grifols, S.A. (GRFS)

Insider Monkey

7 months ago

Here’s White Falcon’s Views on Grifols, S.A. (GRFS)

IBL partners with Grifols to develop biomarker panels for speciality diagnostics

Medical Device Network

8 months ago

IBL partners with Grifols to develop biomarker panels for speciality diagnostics

Exploring High Growth Tech Stocks In Europe April 2025

Simply Wall St.

8 months ago

Exploring High Growth Tech Stocks In Europe April 2025

MT Newswires

8 months ago

European Equities Close Lower in Wednesday Trading; Brookfield in Talks Again to Acquire Grifols

MT Newswires

8 months ago

Sector Update: Health Care Stocks Fall Pre-Bell Wednesday

MT Newswires

8 months ago

Market Chatter: Brookfield Resumes Discussions for Potential Grifols Deal

Spanish pharma company Grifols' shares up on Brookfield talk

Reuters

8 months ago

Spanish pharma company Grifols' shares up on Brookfield talk

High Growth Tech Stocks in Europe for March 2025

Simply Wall St.

9 months ago

High Growth Tech Stocks in Europe for March 2025

MT Newswires

9 months ago

Grifols Aims to Double Revenue Over Next Decade

Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

9 months ago

Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?

Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...

GuruFocus.com

9 months ago

Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...

MT Newswires

9 months ago

Grifols to Appoint Anne-Catherine Berner as Chair

Exploring High Growth Tech Stocks In February 2025

Simply Wall St.

10 months ago

Exploring High Growth Tech Stocks In February 2025

Gotham, Grifols Eye Two Separate Regulator Reports Ahead of Legal Standoff

Bloomberg

10 months ago

Gotham, Grifols Eye Two Separate Regulator Reports Ahead of Legal Standoff

MT Newswires

10 months ago

Grifols Gets $21 Million Grant to Identify Early Parkinson's Disease Biomarkers

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease

GlobeNewswire

10 months ago

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease

Mason Capital complains about Grifols' transparency to Spanish regulator

Reuters

10 months ago

Mason Capital complains about Grifols' transparency to Spanish regulator

Exploring Three High Growth Tech Stocks For Future Potential

Simply Wall St.

a year ago

Exploring Three High Growth Tech Stocks For Future Potential

Grifols’ Worst-Ever Year Can’t Derail Analyst Calls to Buy

Bloomberg

a year ago

Grifols’ Worst-Ever Year Can’t Derail Analyst Calls to Buy

Grifols Keeps Door Open to Brookfield With Special Bond Term

Bloomberg

a year ago

Grifols Keeps Door Open to Brookfield With Special Bond Term

MT Newswires

a year ago

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Market Chatter: Grifols' Debt Placement Includes Early Redemption Option for Brookfield Asset Management

Flat Footed Asks Grifols to Reform Board to Protect Shareholders

Bloomberg

a year ago

Flat Footed Asks Grifols to Reform Board to Protect Shareholders

Morningstar Research

a year ago

Analyst Report: Grifols, S.A.

SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts

Bloomberg

a year ago

SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts

Exploring High Growth Tech Stocks This December 2024

Simply Wall St.

a year ago

Exploring High Growth Tech Stocks This December 2024

Grifols Shareholder Mason Capital Calls for Board Overhaul

Bloomberg

a year ago

Grifols Shareholder Mason Capital Calls for Board Overhaul

MT Newswires

a year ago

Sector Update: Health Care Stocks Slipping Late Afternoon

MT Newswires

a year ago

Market Chatter: Grifols Shareholder Mason Capital Seeks Board Revamp

MT Newswires

a year ago

Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

Benzinga

a year ago

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

Grifols Stock Declines After Brookfield Drops Buyout Offer

Zacks

a year ago

Grifols Stock Declines After Brookfield Drops Buyout Offer

Billionaire Grifols Family Woes in Focus as Brookfield Exits

Bloomberg

a year ago

Billionaire Grifols Family Woes in Focus as Brookfield Exits

Grifols In Talks to Refinance Debt, Credit Line, CEO Says

Bloomberg

a year ago

Grifols In Talks to Refinance Debt, Credit Line, CEO Says

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Top Midday Decliners

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance Wednesday Afternoon

MT Newswires

a year ago

Update: Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols

Bloomberg

a year ago

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols

MT Newswires

a year ago

Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others

Brookfield Set to Drop Grifols Bid as Family Shuns Others

Bloomberg

a year ago

Brookfield Set to Drop Grifols Bid as Family Shuns Others

MT Newswires

a year ago

Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Zacks

a year ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

Clinical Trials Arena

a year ago

GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

Grifols Signals It Would Reject $6.8 Billion Brookfield Bid

Bloomberg

a year ago

Grifols Signals It Would Reject $6.8 Billion Brookfield Bid

Morningstar Research

a year ago

Analyst Report: Grifols, S.A.

MT Newswires

a year ago

Brookfield Asset Management Mulls $6.8 Billion Bid for Grifols

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

GlobeNewswire

a year ago

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop

Bloomberg

a year ago

Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop

MT Newswires

a year ago

Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Bloomberg

a year ago

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

GuruFocus.com

a year ago

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

Morningstar Research

a year ago

Analyst Report: Grifols, S.A.

MT Newswires

a year ago

Market Chatter: Brookfield Asset Management Seeks Details of Grifols Related-Party Deals

Brookfield Seeks More Information on Grifols Related-Party Deals

Bloomberg

a year ago

Brookfield Seeks More Information on Grifols Related-Party Deals

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.

a year ago

High Growth Tech Stocks to Watch in November 2024

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Simply Wall St.

a year ago

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Grifols receives FDA approval to treat surgical bleeding with FS solution

TipRanks

a year ago

Grifols receives FDA approval to treat surgical bleeding with FS solution

MT Newswires

a year ago

Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

GlobeNewswire

a year ago

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

MT Newswires

a year ago

Grifols Teams Up With BARDA to Test Treatment for Eye Injuries Caused by Mustard Gas

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

GlobeNewswire

a year ago

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

MT Newswires

a year ago

Grifols Unit Wins US Government Contract to Develop Botulinum Neurotoxin Therapy

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

a year ago

High Growth Tech Stocks To Watch In October 2024

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

GlobeNewswire

a year ago

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

MT Newswires

a year ago

Market Chatter: Brookfield Seeks More Time to Complete Due Diligence for Possible Grifols Takeover Bid

MT Newswires

a year ago

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires

a year ago

Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

Bloomberg

a year ago

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

Zacks

a year ago

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

MT Newswires

a year ago

Market Chatter: Grifols Seeking Consultants to Fend off Shareholder Challenge

MT Newswires

a year ago

Grifols Egypt Partners With Orange for Data Center, Communications Infrastructure

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Bloomberg

a year ago

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Share on Social Networks: